@FiercePharma: Probe suggests J&J, FDA in tug of war over recall. Report | Follow @FiercePharma
> A day after Genmab's battered stock spiked following renewed rumors of a GlaxoSmithKline takeover, CEO Lisa Drakeman (photo) has stepped down from the helm. She will be replaced by the developer's chief scientific officer. Genmab news
> Genzyme is not for sale, after resolving a proxy contest with billionaire investor Carl Icahn, CEO Henri Termeer said. Report
> GlaxoSmithKline has won the FDA nod for a fixed-dose combination prostate drug called called Jalyn, combining dutasteride (Avodart) and tamsulosin (Flomax). Report
> Takeda Pharmaceutical (4502.T), on Tuesday launched three drugs in the Japanese market, forecasting combined annual sales of 10 billion yen ($109.2 million). Report
> A generic drug that costs less than $10 a treatment--sold by Pfizer under the brand name Cyklokapron--may save as many as 100,000 lives a year by preventing people from bleeding to death after accidents, researchers said. Report
> Genzyme said U.S. regulators have granted fast-track status to the biotechnology company's experimental treatment for multiple sclerosis. Report
Biotech News
@FierceBiotech: Analysis: Fewer approvals may prove R&D is getting tougher. Report | Follow @FierceBiotech
@JohnCFierce: NYT's Pollack makes some good points on genomics, but it takes 15 years to start a biotech revolution and 15 more to profit. Report | Follow @JohnCFierce
> FDA: New "morning-after" pill appears safe, effective. Report
> FoldRx banks $29M for neurodegenerative drug application. Article
> Trubion slumps after Pfizer kills lead RA drug program. Report
Pharma Manufacturing News
> Genzyme troubles show challenge of fast-moving tech. Story
> Bribery allegations torment China's drug regulator. News
> Sudan wants U.S. compensation for pharma plant bombing. Report
> Novavax, CPL complete Indian vax facility. Piece
> Genzyme rehab creates bio-supplier stimulus package. News
Biotech Research News
> Team creates working segment of complex liver tissue. News
> Antibiotic experts demand new incentives to spur R&D work. Article
> Westphal offers optimistic outlook for regenerative medicine. Story
> Breakthrough plastic antibodies guard mice against venom. Report
And Finally... For the forgetful, cash helps the medicine go down. Report